T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
1326
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $9.08M | ﹤0.01% |
+453,374
| New | +$9.08M |
|
1327
Donaldson
DCI
$11.1B
| $9.02M | ﹤0.01% |
177,347
-16,971
| -9% | -$863K |
|
1328
Tenable Holdings
TENB
$4.41B
| $9M | ﹤0.01% |
+315,338
| New | +$9.33M |
|
1329
ON Semiconductor
ON
$31.8B
| $8.99M | ﹤0.01% |
444,689
+14,214
| +3% | +$294K |
|
1330
Zillow
ZG
$8.15B
| $8.97M | ﹤0.01% |
196,055
-1,381,290
| -88% | -$54.2M |
|
1331
Leggett & Platt
LEG
$1.32B
| $8.89M | ﹤0.01% |
231,810
-5,156
| -2% | -$203K |
|
1332
Enpro
NPO
$7.12B
| $8.87M | ﹤0.01% |
138,983
+110,235
| +383% | +$7.2M |
|
1333
Warner Bros
WBD
$69.6B
| $8.81M | ﹤0.01% |
287,140
-1,100
| -0.4% | -$32K |
|
1334
Sprott Physical Gold and Silver Trust
CEF
$8.17B
| $8.65M | ﹤0.01% |
654,189
-13,600
| -2% | -$170K |
|
|
ZUO
1335
DELISTED
Zuora, Inc.
ZUO
| $8.62M | ﹤0.01% |
562,412
-495,541
| -47% | -$9.39M |
|
|
USX
1336
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $8.62M | ﹤0.01% |
1,676,050
+183,811
| +12% | +$1.12M |
|
1337
Under Armour Class C
UA
$2.25B
| $8.61M | ﹤0.01% |
387,754
-4,650
| -1% | -$96.7K |
|
|
CETV
1338
DELISTED
Central European Media Enterprises Ltd
CETV
| $8.59M | ﹤0.01% |
1,971,212
+211
| +0% | +$835 |
|
1339
Genpact
G
$5.78B
| $8.59M | ﹤0.01% |
225,416
-19,052
| -8% | -$693K |
|
|
AXON
1340
Axon Enterprise
AXON
$50B
| $8.55M | ﹤0.01% |
133,233
-15,184
| -10% | -$990K |
|
1341
ManpowerGroup
MAN
$2.75B
| $8.44M | ﹤0.01% |
87,314
-1,000
| -1% | -$91.1K |
|
1342
Standex International
SXI
$3.97B
| $8.43M | ﹤0.01% |
115,199
-1,481
| -1% | -$105K |
|
1343
Minerva Neurosciences
NERV
$187M
| $8.34M | ﹤0.01% |
185,225
-11,506
| -6% | -$576K |
|
|
GRUB
1344
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $8.29M | ﹤0.01% |
53,130
-100,090
| -65% | -$13.6M |
|
1345
Under Armour
UAA
$2.3B
| $8.21M | ﹤0.01% |
323,773
-5,729
| -2% | -$134K |
|
|
CCI.PRA
1346
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $8.01M | ﹤0.01% |
6,690
| – | – |
|
1347
Personalis
PSNL
$1.54B
| $8.01M | ﹤0.01% |
+294,829
| New | +$8.34M |
|
|
EPZM
1348
DELISTED
Epizyme, Inc
EPZM
| $7.98M | ﹤0.01% |
635,663
+231,109
| +57% | +$2.97M |
|
1349
Liberty Media Series C
FWONK
$26B
| $7.92M | ﹤0.01% |
219,032
-5,918
| -3% | -$215K |
|
|
CSS
1350
DELISTED
CSS Industries, Inc.
CSS
| $7.87M | ﹤0.01% |
1,612,099
-25,701
| -2% | -$150K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.